Out of interest from one of the research reports on sale.
"GlobalData estimates the 2013 sales for acromegaly and gigantism at approximately $588m across the 6MM covered in this report. The market will grow moderately at a CAGR of 3.74% during the five year forecast period, generating sales of approximately $707m at the end of 2018. Growing at a CAGR of 4.58% and generating around 68% of global sales in 2018, the US market will experience twice the rate of growth of the 5EU market. Two major trends are visible among the pipeline drugs and research and development (R&D) strategies employed by companies in this chronic disease space – a focus towards the treatment of refractory patients and the improvement of drug delivery mechanisms to increase patient convenience."
"Although the standard treatments are effective in most patients, a growing number of patients are being discovered who remain uncontrolled by current therapy. Treatment of this patient segment presents a major unmet need in this market."
- Forums
- ASX - By Stock
- ISIS and Alnylam Starting to Walk the Talk
Out of interest from one of the research reports on sale....
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.3¢ |
Change
0.002(2.47%) |
Mkt cap ! $74.82M |
Open | High | Low | Value | Volume |
9.0¢ | 9.0¢ | 8.2¢ | $9.57K | 112.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 124862 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 11000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 124862 | 0.081 |
4 | 62665 | 0.080 |
1 | 9500 | 0.078 |
1 | 30100 | 0.077 |
1 | 5000 | 0.076 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 11000 | 1 |
0.090 | 105882 | 1 |
0.092 | 100000 | 1 |
0.093 | 46625 | 1 |
0.094 | 107837 | 1 |
Last trade - 15.56pm 29/03/2024 (20 minute delay) ? |
|
|||||
Last
8.2¢ |
  |
Change
0.002 ( 0.86 %) |
|||
Open | High | Low | Volume | ||
8.2¢ | 8.3¢ | 8.2¢ | 31700 | ||
Last updated 15.55pm 29/03/2024 ? |
Featured News
PER (ASX) Chart |
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online